7-Nitroindazole enhances dose-dependently the anticonvulsant activities of conventional antiepileptic drugs in the mouse maximal electroshock-induced seizure model

Pharmacological Reports

Volumn 58, Issue 5, 2006, Pages 660-671

  Łuszczki, Jarogniew J ^a   Sacharuk, Anna ^a   Wojciechowska, Anna ^a   Andres Mach, Marta M ^b   Dudra Jastrzebska, Monika ^b   Mohamed, Mohamed ^a   Sawicka, Katarzyna M ^a   Kozińska, Justyna ^a   Czuczwar, Stanisław J ^a,b  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

^b INSTITUTE OF AGRICULTURAL MEDICINE   (Poland)

Author keywords

7 Nitroindazole; Carbamazepine; Electroconvulsive threshold; L arginine; Maximal electroshock; Nitric oxide; Pharmacodynamic pharmacokinetic interactions; Phenobarbital; Phenytoin; Spontaneous locomotor activity; Valproate

Indexed keywords

7 NITROINDAZOLE; ANTICONVULSIVE AGENT; ARGININE; CARBAMAZEPINE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE INHIBITOR; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CONVULSION; DOSE RESPONSE; DRUG BRAIN LEVEL; DRUG POTENTIATION; ELECTRIC SHOCK; LINEAR REGRESSION ANALYSIS; LOCOMOTION; MALE; MOUSE; NONHUMAN; SEIZURE; STATISTICAL ANALYSIS;

EID: 33751012426     PISSN: 22995684     EISSN: 22995684     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Araki T, Mizutani H, Matsubara M, Imai Y, Mizugaki M, Itoyama Y: Nitric oxide synthase inhibitors cause motor deficits in mice. Eur Neuropsychopharmacol, 2001, 11, 125-133.
2. Aricioglu F, Kan B, Yillar O, Korcegez E, Berkman K: Effect of agmatine on electrically and chemically induced seizures in mice. Ann N Y Acad Sci, 2003, 1009, 141-146.
3. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK: Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol, 1993, 110, 225-228.
4. Baran L, Siwanowicz; J, Przegalinski E: Effect of nitric oxide synthase inhibitors and molsidomine on the anti-convulsant activity of some antiepileptic drugs. Pol J Pharmacol, 1997, 49, 363-368.
5. Borowicz KK, Kleinrok Z, Czuczwar SJ: Influence of 7-nitroindazole on the anticonvulsive action of conventional antiepileptic drugs. Eur J Pharmacol, 1997, 331, 127-132.
6. Borowicz KY, Kleinrok Z, Czuczwar SJ: 7-Nitroindazole differentially affects the anticonvulsant activity of antiepileptic drugs against amygdala-kindled seizures in rats. Epilepsia, 2000, 41, 1112-1118.
7. Borowicz KK, Luszczki J, Kleinrok Z, Czuczwar SJ: 7-Nitroindazole, a nitric oxide synthase inhibitor, enhances the anticonvulsive action of ethosuximide and clonazepam against pentylenetetrazol-induced convulsions. J Neural Transm, 2000, 107, 1117-1126.
8. Bredt DS, Snyder SH: Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA, 1990, 87, 682-685.
9. Buisson A, Lakhmeche N, Verrecchia C, Plotkine M, Boulu RG: Nitric oxide: an endogenous anticonvulsant substance. Neuroreport, 1993, 4, 444-446.
10. Cadart M, Marchand S, Pariat C, Bouquet S, Couet W: Ignoring pharmacokinetics may lead to isoboles misinterpretation: illustration with the norfloxacin-theophylline convulsant interaction in rats. Pharm Res, 2002, 19, 209-214.
11. Dawson TM, Snyder SH: Gases as biological messengers: nitric oxide and carbon monoxide in the brain. J Neurosci, 1994, 14, 5147-5159.
12. De Sarro G, Di Paola ED, De Sarro A, Vidal MJ: L-arginine potentiates excitatory amino acid-induced seizures elicited in the deep prepiriform cortex. Eur J Pharmacol, 1993, 230, 151-158.
13. De Sarro G, Gareri P, Falconi U, De Sarro A: 7-Nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice. Eur J Pharmacol, 2000, 394, 275-288.
14. Deutsch SI, Rosse RB, Morn C, Koetzner L, Mastropaolo J: Interference with nitric oxide production and action potentiates the antiseizure efficacy of flurazepam. Pharmacol Biochem Behav, 1995, 51, 133-137.
15. D'Mello GD, Steckler T: Animal models in cognitive behavioural pharmacology: an overview. Brain Res Cogn Brain Res, 1996, 3, 345-352.
16. Dzoljic E, De Vries R, Dzoljic MR: Anticonvulsant activity of new and potent inhibitors of nitric oxide synthase. Brain Res Bull, 1997, 43, 191-195.
17. Eblen F, Loschmann PA, Wullner U, Turski L, Klockgether T: Effects of 7-nitroindazole, NG-nitro-L-arginine, and D-CPPene on harmaline-induced postural tremor, N-methyl-D-aspartate-induced seizures, and lisuride-induced rotations in rats with nigral 6-hydroxydopamine lesions. Eur J Pharmacol, 1996, 299, 9-16.
18. Feng Y, LeBlanc MH, Regunathan S: Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anti-convulsive effects. Neurosci Lett, 2005, 390, 129-133.
19. Garthwaite J: Glutamate, nitric oxide and cell-cell signalling in the nervous system. Trends Neurosci, 1991, 14, 60-67.
20. Glantz SA, Slinker BK: Primer of applied regression & analysis of variance. 2nd edn., McGraw-Hill Inc., New York, 2001.
21. Hodges H: Maze procedures: the radial-arm and water maze compared. Cognit Brain Res, 1996, 3, 167-181.
22. Jones PA, Smith RA, Stone TW: Nitric oxide synthase inhibitors L-NAME and 7-nitroindazole protect rat hippocampus against kainate-induced excitotoxicity. Neurosci Lett, 1998, 249, 75-78.
23. Kirkby RD, Forbes RA, Subramaniam S: Modification of kainate-induced behavioral and electrographic seizures following inhibition of nitric oxide synthase in mice. Epilepsy Res, 1996, 24, 79-90.
24. Kuriyama K, Ohkuma S: Role of nitric oxide in central synaptic transmission: effects on neurotransmitter release. Jpn J Pharmacol, 1995, 69, 1-8.
25. Lallement G, Shih TM, Pernot-Marino I, Baubichon D, Foquin A, McDonough JH: The role of nitric oxide in soman-induced seizures, neuropathology, and lethality. Pharmacol Biochem Behav, 1996, 54, 731-737.
26. Li G, Regunathan S, Barrow CJ, Eshraghi J, Cooper R, Reis DJ. Agmatine: an endogenous clonidine-displacing substance in the brain. Science, 1994, 263, 966-969.
27. Litchfield JT, Wilcoxon F: A simplified method of evaluating dose-effect experiments. J Pharmacol Exp Ther, 1949, 96, 99-113.
28. Lonart G, Wang J, Johnson KM: Nitric oxide induces neurotransmitter release from hippocampal slices. Eur J Pharmacol, 1992, 220, 271-272.
29. Łuszczki JJ, Borowicz; KK, Świader M, Czuczwar SJ: Interactions between oxcarbazepine and conventional antiepileptic drugs in the maximal electroshock test in mice: an isobolographic analysis. Epilepsia, 2003, 44, 489-499.
30. Łuszczki JJ, Czuczwar M, Gawlik P, Sawiniec-Późniak G, Czuczwar K, Czuczwar SJ: 7-Nitroindazole potentiates the anticonvulsant action of some second-generation antiepileptic drugs in the mouse maximal electroshock-induced seizure model. J Neural Transm, 2006, 113, 1157-1168.
31. Łuszczki JJ, Czuczwar SJ: Preclinical profile of combinations of some second-generation antiepileptic drugs: an isobolographic analysis. Epilepsia, 2004, 45, 895-907.
32. Łuszczki JJ, Czuczwar SJ: How significant is the difference between drug doses influencing the threshold for electroconvulsions? Pharmacol Rep, 2005, 57, 782-786.
33. Łuszczki JJ, Kozicka. M, Świader MJ, Czuczwar SJ: 2-Chloro-N(6)-cyclopentyladenosine enhances the anticonvulsant action of carbamazepine in the mouse maximal electroshock-induced seizure model. Pharmacol Rep, 2005, 57, 787-794.
34. Łuszczki JJ, Mohamed M, Czuczwar SJ: 2-Phosphonomethyl-pentanedioic acid (glutamate carboxypeptidase II inhibitor) increases threshold for electroconvulsions and enhances the antiseizure action of valproate against maximal electroshock-induced seizures in mice. Eur J Pharmacol, 2006, 531, 66-73.
35. Łuszczki JJ, Świader M, Czuczwar M, Kiś J, Czuczwar SJ:Interactions of tiagabine with some antiepileptics in the maximal electroshock in mice. Pharmacol Biochem Behav, 2003, 75, 319-327.
36. MacKenzie GM, Rose S, Bland-Ward PA, Moore PK, Jenner P, Marsden CD: Time course of inhibition of brain nitric oxide synthase by 7-nitroindazole. Neuroreport, 1994, 5, 1993-1996.
37. Manzoni O, Prezeau L, Marin P, Deshager S, Bockaert J, Fagni L: Nitric oxide-induced blockade of NMDA receptors. Neuron, 1992, 8, 653-662.
38. Marangoz C, Ayyildiz M, Agar E: Evidence that sodium nitroprusside possesses anticonvulsant effects mediated through nitric oxide. Neuroreport, 1994, 5, 2454-2456.
39. Masukawa T, Nakanishi K, Natsuki R: Role of nitric oxide in the convulsions following the coadministration of enoxacin with fenbufen in mice. Jpn J Pharmacol, 1998, 76, 425-429.
40. Mollace V, Bagetta G, Nistico G: Evidence that L-arginine possesses proconvulsant effects mediated through nitric oxide. Neuroreport, 1991, 2, 269-272.
41. Moncada S, Palmer RM, Higgs EA: Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev, 1991, 43, 109-142.
42. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC: Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: antinociceptive and cardiovascular effects. Br J Pharmacol, 1993, 110, 219-224.
43. Morris SM Jr: Enzymes of arginine metabolism. J Nutr, 2004, 134, Suppl 10, 2743S-2747S.
44. Mülsch A, Busse R, Mordvintcev PI, Vanin AF, Nielsen EO, Scheel-Kruger J, Olesen SP: Nitric oxide promotes seizure activity in kainate-treated rats. Neuroreport, 1994, 5, 2325-2328.
45. Murashima YL, Yoshii M, Suzuki J: Ictogenesis and epileptogenesis in EL mice. Epilepsia, 2002, 43, Suppl 5, 130-135.
46. Paul V: Evidence for the involvement of L-citrulline but not nitric oxide in the proconvulsant action of the precursor L-arginine on picrotoxin-induced convulsions in rats. Biochem Pharmacol, 2002, 63, 2019-2023.
47. Paul V: The effect of N-nitro-L-arginine methyl ester posttreatment on the anticonvulsant effect of phenobarbitone and diazepam on picrotoxin-induced convulsions in rats. Pharmacol Biochem Behav, 2003, 74, 789-794.
48. Paul V, Ekambarain P: Effect of 7-nitroindazole alone and in combination with phenobarbitone and diazepam on picrotoxin-induced convulsions in rats. Indian J Physiol Pharmacol, 2003, 47, 400-406.
49. Paul V, Jayakumar AR: A role of nitric oxide as an inhibitor of gamma-aminobutyric acid transaminase in rat brain. Brain Res Bull, 2000, 51, 43-46.
50. Paul V, Subramanian EH: Evidence for an involvement of nitric oxide and gamma aminobutyric acid in the anti-convulsant action of L-arginine on picrotoxin-induced convulsions in rats. Pbarmacol Biochem Behav, 2002, 72, 515-519.
51. Przegaliński E, Baran L, Siwanowicz J: The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci Lett, 1996, 217, 145-148.
52. Rejasekaran K, Jayakumar R, Venkatachalam K: Increased neuronal nitric oxide synthase (nNOS) activity triggers picrotoxin-induced seizures in rats and evidence for participation of nNOS mechanism in the action of antiepileptic drugs. Brain Res, 2003, 979, 85-97.
53. Schmidt D, Elger CE: What is the evidence that oxcarbazepine and carbamazepine are distinctly different antiepileptic drugs? Epilepsy Behav, 2004, 5, 627-635.
54. Segovia G, Mora F: Role of nitric oxide in modulating the release of dopamine, glutamate, and GABA in striatum of the freely moving rat. Brain Res Bull, 1998, 45, 275-279.
55. Smith SE, Man CM, Yip PK, Tang E, Chapman AG, Meldrum BS: Anticonvulsant effects of 7-nitroindazole in rodents with reflex epilepsy may result from L-arginine accumulation or a reduction in nitric oxide or L-citrulline formation. Br J Pharmacol, 1996, 119, 165-173.
56. Su RB, Wei XL, Zheng JQ, Liu Y, Lu XQ, Li J: Anticonvulsive effect of agmatine in mice. Pharmacol Biochem Behav, 2004, 77, 345-349.
57. Vanaja P, Ekambaram P: Demonstrating the dose- and time-related effects of 7-nitroindazole on picrotoxin-induced convulsions, memory formation, brain nitric oxide synthase activity, and nitric oxide concentration in rats. Pharmacol Biochem Behav, 2004, 77, 1-8.
58. Van Leeuwen R, De Vries R, Dzoljic MR: 7-Nitro indazole, an inhibitor of neuronal nitric oxide synthase, attenuates pilocarpine-induced seizures. Eur J Pharmacol, 1995, 287, 211-213.
59. Volke V, Wegener G, Bourin M, Vasar E: Antidepressant- and anxiolytic-like effects of selective neuronal NOS inhibitor 1-(2-trifluoromethylphenyl)-imidazole in mice. Behav Brain Res, 2003, 140, 141-147.
60. Wang Q, Theard MA, Pelligrino DA, Baughman VL, Hoffman WE, Albrecht RF, Cwik M, et al.: Nitric oxide (NO) is an endogenous anticonvulsant but not a mediator of the increase in cerebral blood flow accompanying bicuculline-induced seizures in rats. Brain Res, 1994, 658, 192-198.
61. Wojtal K, Gniatkowska-Nowakowska A, Czuczwar SJ: Is nitric oxide involved in the anticonvulsant action of antiepileptic drugs? Pol J Pharmacol, 2003, 55, 535-542.
62. Yildiz F, Erden BF, Ulak G, Utkan T, Gacar N: Antidepressant-like effect of 7-nitroindazole in the forced swimming test in rats. Psychopharmacology, 2000, 149, 41-44.
63. Yildiz: F, Ulak G, Erden BF, Gacar N: Anxiolytic-like effects of 7-nitroindazole in the rat plus-maze test. Pharmacol Biochem Behav, 2000, 65, 199-202.